Leadership Leadership

Leadership

Bernard Coulie, M.D., Ph.D.
Bernard Coulie, M.D., Ph.D.

President and Chief Executive Officer

Keith Cummings, M.D., MBA
Keith Cummings, M.D., MBA

Chief Financial Officer

Lily Cheung
Lily Cheung

Chief Human Resources Officer

S. Mishima Gerhart
S. Mishima Gerhart

Chief Regulatory Officer

Hans Hull, J.D.
Hans Hull, J.D.

Chief Business Officer

Delphine Imbert, Ph.D.
Delphine Imbert, Ph.D.

Chief Technical Officer

Minnie Kuo
Minnie Kuo

Chief Development Officer

Éric Lefebvre, M.D.
Éric Lefebvre, M.D.

Chief Medical Officer

Tim Machajewski, Ph.D.
Tim Machajewski, Ph.D.

Senior Vice President, Head of Research

Gary Palmer, M.D., MBA
Gary Palmer, M.D., MBA

Senior Vice President, Medical Affairs

Chohee Yun, M.D.
Chohee Yun, M.D.

Senior Vice President, Clinical Development

Shuguang Zhu, Ph.D.
Shuguang Zhu, Ph.D.

Senior Vice President, Chemistry, Manufacturing & Controls (CMC)

Christopher Barnes, Ph.D.
Christopher Barnes, Ph.D.

Vice President, Biometrics

Gregory P. Cosgrove, M.D., FCCP
Gregory P. Cosgrove, M.D., FCCP

Vice President, Clinical Development

Martin Decaris, Ph.D.
Martin Decaris, Ph.D.

Vice President, Translational Sciences

Eric Giguere
Eric Giguere

Vice President, Quality

Christopher Keenan
Christopher Keenan

Vice President, Investor Relations and Corporate Communications

Eve-Irene Lepist, Ph.D.
Eve-Irene Lepist, Ph.D.

Vice President, Non-Clinical Development

Mike Ouimette, J.D.
Mike Ouimette, J.D.

General Counsel and Corporate Secretary

Daniel Park
Daniel Park

Vice President, Business Operations

Scott Peters
Scott Peters

Vice President, Finance and Corporate Controller

Fernando Rock, Ph.D.
Fernando Rock, Ph.D.

Vice President, Drug Discovery

Johanna Colvin Riesen
Johanna Colvin Riesen

Vice President, Clinical Operations

Monica Sandberg, Ph.D.
Monica Sandberg, Ph.D.

Vice President, Regulatory Affairs

Diana Vazquez
Diana Vazquez

Vice President, Supply Chain Management

Our Team

Pliant is led by a team of world-renowned fibrosis researchers and highly experienced drug developers focused on translating science into novel therapies for patients in need.